|
1
|
Brumback LC, Andrews LIB, Jacobs DR Jr,
Duprez DA, Shah SJ, Dougherty CM, Denenberg JO and Allison MA: The
association between indices of blood pressure waveforms (PTC1 and
PTC2) and incident heart failure. J Hypertens. 39:661–666.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Harrison N, Pang P, Collins S and Levy P:
Blood pressure reduction in hypertensive acute heart failure. Curr
Hypertens Rep. 23(11)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hering D, Esler MD, Krum H, Mahfoud F,
Böhm M, Sobotka PA and Schlaich MP: Recent advances in the
treatment of hypertension. Expert Rev Cardiovasc Ther. 9:729–744.
2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rodrigo R, González J and Paoletto F: The
role of oxidative stress in the pathophysiology of hypertension.
Hypertens Res. 34:431–440. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pierini D and Bryan NS: Nitric oxide
availability as a marker of oxidative stress. Methods Mol Biol.
1208:63–71. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang ZM, Zhang JX, Li B, Gao X, Liu Y, Mao
W and Chen SL: Resveratrol ameliorates low shear stress-induced
oxidative stress by suppressing ERK/eNOS-Thr495 in endothelial
cells. Mol Med Rep. 10:1964–1972. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li XC, Zhang J and Zhuo JL: The
vasoprotective axes of the renin-angiotensin system: Physiological
relevance and therapeutic implications in cardiovascular,
hypertensive and kidney diseases. Pharmacol Res. 125:21–38.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fyhrquist F and Saijonmaa O:
Renin-angiotensin system revisited. J Intern Med. 264:224–236.
2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lee HS, Park HK, Kim KH, Ko JH, Kim YJ, Yi
KH and Hwang JS: Estrogen receptor α gene analysis in girls with
central precocious puberty. J Pediatr Endocrinol Metab. 26:645–649.
2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Demissie S, Cupples LA, Shearman AM,
Gruenthal KM, Peter I, Schmid CH, Karas RH, Housman DE, Mendelsohn
ME and Ordovas JM: Estrogen receptor-alpha variants are associated
with lipoprotein size distribution and particle levels in women:
The Framingham heart study. Atherosclerosis. 185:210–218.
2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chlebowski RT, Anderson GL, Geller M and
Col N: Coronary heart disease and stroke with aromatase inhibitor,
tamoxifen, and menopausal hormone therapy use. Clin Breast Cancer.
6 (Suppl 2):S58–S64. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nordenskjold B, Rosell J, Rutqvist LE,
Malmström PO, Bergh J, Bengtsson NO, Hatschek T, Wallgren A and
Carstensen J: Coronary heart disease mortality after 5 years of
adjuvant tamoxifen therapy: Results from a randomized trial. J Natl
Cancer Inst. 97:1609–1610. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sharma D, Sharma U, Bhatnagar VB and Singh
VS: A study of the effect of tamoxifen on serum lipoprotein
profiles in premenopausal and postmenopausal women with breast
carcinoma and associated risk of cardiovascular disease. Indian J
Med Sci. 55:359–365. 2001.PubMed/NCBI
|
|
14
|
McLean BA, Zhabyeyev P, Patel VB, Basu R,
Parajuli N, DesAulniers J, Murray AG, Kassiri Z, Vanhaesebroeck B
and Oudit GY: PI3Kalpha is essential for the recovery from
Cre/tamoxifen cardiotoxicity and in myocardial insulin signalling
but is not required for normal myocardial contractility in the
adult heart. Cardiovasc Res. 105:292–303. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shi W, Ma H, Liu T, Yan D, Luo P, Zhai M,
Tao J, Huo S, Guo J, Li C, et al: Inhibition of
Interleukin-6/glycoprotein 130 signalling by Bazedoxifene
ameliorates cardiac remodelling in pressure overload mice. J Cell
Mol Med. 24:4748–4761. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
McKeand W, Ermer J and Korth-Bradley J:
Assessment of the effects of age and renal function on
pharmacokinetics of bazedoxifene in postmenopausal women. Clin
Pharmacol Drug Dev. 7:920–926. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Clarkson TB, Ethun KF, Pajewski NM, Golden
D, Floyd E and Appt SE: Effects of bazedoxifene, conjugated equine
estrogens, and a tissue-selective estrogen complex containing both
bazedoxifene and conjugated equine estrogens on cerebral artery
atherosclerosis in postmenopausal monkeys. Menopause. 21:8–14.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Martinez-Arroyo O, Ortega A, Galera M,
Solaz E, Martinez-Hervas S, Redon J and Cortes R: Decreased urinary
levels of SIRT1 as non-invasive biomarker of early renal damage in
hypertension. Int J Mol Sci. 21(6390)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang R, Fang W, Liang J, Lin C, Wu S, Yan
S, Hu C and Ke X: Apelin/APJ axis improves angiotensin II-induced
endothelial cell senescence through AMPK/SIRT1 signaling pathway.
Arch Med Sci. 14:725–734. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ishibashi Y, Matsui T, Ueda S, Fukami K,
Okuda S, Ohta H and Yamagishi S: Bazedoxifene blocks
AGEs-RAGE-induced superoxide generation and MCP-1 level in
endothelial cells. Climacteric. 18:426–430. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang XY, Li XY, Wu CH, Hao Y, Fu PH, Mei
HX, Chen F, Gong YQ, Jin SW and Li H: Protectin conjugates in
tissue regeneration 1 restores lipopolysaccharide-induced pulmonary
endothelial glycocalyx loss via ALX/SIRT1/NF-kappa B axis. Respir
Res. 22(193)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expres- sion data using real-time quantitative PCR
and the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gao D, Zuo Z, Tian J, Ali Q, Lin Y, Lei H
and Sun Z: Activation of SIRT1 attenuates klotho deficiency-induced
arterial stiffness and hypertension by enhancing AMP-activated
protein kinase activity. Hypertension. 68:1191–1199.
2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ding Y, Chen J, Cui G, Wei Y, Lu C, Wang L
and Diao H: Pathophysiological role of osteopontin and angiotensin
II in atherosclerosis. Biochem Biophys Res Commun. 471:5–9.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wei F, Liu S, Luo L, Gu N, Zeng Y, Chen X,
Xu S and Zhang D: Anti-inflammatory mechanism of ulinastatin:
Inhibiting the hyperpermeability of vascular endothelial cells
induced by TNF-α via the RhoA/ROCK signal pathway. Int
Immunopharmacol. 46:220–227. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yamawaki H, Kameshima S, Usui T, Okada M
and Hara Y: A novel adipocytokine, chemerin exerts
anti-inflammatory roles in human vascular endothelial cells.
Biochem Biophys Res Commun. 423:152–157. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fan X, Wang E, He J, Zhang L, Zeng X, Gui
Y, Sun Q, Song Y and Yuan H: Ligustrazine protects
homocysteine-induced apoptosis in human umbilical vein endothelial
cells by modulating mitochondrial dysfunction. J Cardiovasc Transl
Res. 12:591–599. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chan P, Chen YC, Lin LJ, Cheng TH, Anzai
K, Chen YH, Liu ZM, Lin JG and Hong HJ: Tanshinone IIA attenuates
H(2)O(2)-induced injury in human umbilical vein endothelial cells.
Am J Chin Med. 40:1307–1319. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bik E, Mielniczek N, Jarosz M, Denbigh J,
Budzynska R, Baranska M and Majzner K: Tunicamycin induced
endoplasmic reticulum changes in endothelial cells investigated in
vitro by confocal Raman imaging. Analyst. 144:6561–6569.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wassmann S, Laufs U, Stamenkovic D, Linz
W, Stasch JP, Ahlbory K, Rösen R, Böhm M and Nickenig G: Raloxifene
improves endothelial dysfunction in hypertension by reduced
oxidative stress and enhanced nitric oxide production. Circulation.
105:2083–2091. 2002.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Koushki K, Shahbaz SK, Mashayekhi K,
Sadeghi M, Zayeri ZD, Taba MY, Banach M, Al-Rasadi K, Johnston TP
and Sahebkar A: Anti-inflammatory action of statins in
cardiovascular disease: The role of inflammasome and toll-like
receptor pathways. Clin Rev Allergy Immunol. 60:175–199.
2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mostafa TM, Hegazy SK, Elshebini EM, Saif
DS and Elabd AH: A comparative study on the anti-inflammatory
effect of angiotensin-receptor blockers & statins on rheumatoid
arthritis disease activity. Indian J Med Res. 152:393–400.
2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Peppas S, Piovani D, Peyrin-Biroulet L,
Danese S and Bonovas S: Statins and inflammatory bowel disease:
Where do we stand? Eur J Intern Med. 75:10–14. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Orellana-Urzúa S, Rojas I, Líbano L and
Rodrigo R: Pathophysiology of ischemic stroke: Role of oxidative
stress. Curr Pharm Des. 26:4246–4260. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Vanhoutte PM: Nitric oxide: From good to
bad. Ann Vasc Dis. 11:41–51. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Li H and Forstermann U: Nitric oxide in
the pathogenesis of vascular disease. J Pathol. 190:244–254.
2000.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sasaki Y, Ikeda Y, Miyauchi T, Uchikado Y,
Akasaki Y and Ohishi M: Estrogen-SIRT1 axis plays a pivotal role in
protecting arteries against menopause-induced senescence and
atherosclerosis. J Atheroscler Thromb. 27:47–59. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Li L, Gao P, Zhang H, Chen H, Zheng W, Lv
X, Xu T, Wei Y, Liu D and Liang C: SIRT1 inhibits angiotensin
II-induced vascular smooth muscle cell hypertrophy. Acta Biochim
Biophys Sin (Shanghai). 43:103–109. 2011.PubMed/NCBI View Article : Google Scholar
|
